Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

10.94
+0.11001.02%
Post-market: 10.940.00000.00%16:20 EDT
Volume:3.05M
Turnover:33.13M
Market Cap:1.85B
PE:-6.45
High:11.17
Open:10.77
Low:10.65
Close:10.83
52wk High:11.66
52wk Low:4.75
Shares:168.65M
Float Shares:130.00M
Volume Ratio:1.45
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.88
PE(LYR):-3.46

Loading ...

Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities